Q-State Biosciences

About:

Q-State has developed world-leading technologies and proprietary approaches for probing rare and genetic CNS conditions.

Website: http://www.qstatebio.com

Top Investors: National Cancer Institute

Description:

Q-State Biosciences has developed an all-optical electrophysiology platform for controlling and recording activity in electrically active cells: primary and human iPSC-derived cardiomyocytes and neurons. The platform combines proprietary ultrasensitive optogenetic actuators, genetically encoded voltage indicators, stem cell technology and advanced optical imaging. Q-State Biosciences uses custom instrumentation and software to probe cellular physiology with sub-micron spatial resolution and sub-millisecond temporal resolution. Q-State technology probes dynamic cellular physiology with far higher throughput and information content than are achieved with manual patch clamp, multi electrode arrays, or calcium- or voltage-sensitive dyes.

Total Funding Amount:

$22.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2013-01-01

Contact Email:

Info(AT)qstatebio.com

Founders:

Adam Cohen, Celine Hechard, David Margulies, Kevin Eggan

Number of Employees:

51-100

Last Funding Date:

2021-07-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai